Association between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and cancer risk: A meta-analysis and systematic review

Human Immunology

Volumn 75, Issue 8, 2014, Pages 827-832

  Ge, Yu Zheng ^a   Ge, Qian ^b   Li, Ming Hao ^a   Shi, Guo Mei ^a   Xu, Xiao ^b   Xu, Lu Wei ^a   Xu, Zheng ^a   Lu, Tian Ze ^a   Wu, Ran ^a   Zhou, Liu Hua ^a   Wu, Jian Ping ^a   Liang, Kai ^a   Dou, Quan Liang ^a   Zhu, Jia Geng ^a   Li, Wen Cheng ^a   Jia, Rui Peng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b General Hospital of Jiangsu Armed Police   (China)

Author keywords

Cancer; Human leukocyte antigen G; Meta analysis; Polymorphism

Indexed keywords

HLA G ANTIGEN; HUMAN LEUKOCYTE ANTIGEN G 14 BP; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; BLADDER CANCER; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; DNA POLYMORPHISM; ESOPHAGUS CARCINOMA; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INDEL MUTATION; LIVER CELL CARCINOMA; META ANALYSIS; NEUROBLASTOMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THYROID CARCINOMA; UTERINE CERVIX CANCER; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; CASE CONTROL STUDY; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; NEOPLASM; PATHOLOGY; RISK;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-G ANTIGENS; HUMANS; INDEL MUTATION; MALE; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK;

EID: 84905100524     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.06.004     Document Type: Article

References (38)

1. Are C., Rajaram S., Are M., Raj H., Anderson B.O., Chaluvarya Swamy R., et al. A review of global cancer burden: trends, challenges, strategies, and a role for surgeons. J Surg Oncol 2013, 107:221-226.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
3. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
4. Bukur J., Jasinski S., Seliger B. The role of classical and non-classical HLA class I antigens in human tumors. Semin Cancer Biol 2012, 22:350-358.
5. Powell A.G., Horgan P.G., Edwards J. The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?. J Cancer Res Clin Oncol 2012, 138:723-728.
6. Carosella E.D., Moreau P., Lemaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008, 29:125-132.
7. Donadi E.A., Castelli E.C., Arnaiz-Villena A., Roger M., Rey D., Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011, 68:369-395.
8. Loustau M., Wiendl H., Ferrone S., Carosella E.D. HLA-G 2012 conference: the 15-year milestone update. Tissue Antigens 2013, 81:127-136.
9. Jiang Y., Chen S., Jia S., Zhu Z., Gao X., Dong D., et al. Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. DNA Cell Biol 2011, 30:1027-1032.
10. Li X.J., Zhang X., Lin A., Ruan Y.Y., Yan W.H. Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression. Hum Immunol 2012, 73:946-949.
11. Dardano A., Rizzo R., Polini A., Stignani M., Tognini S., Pasqualetti G., et al. Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?. J Clin Endocrinol Metab 2012, 97:4080-4086.
12. Li B.L., Lin A., Zhang X.J., Zhang X., Zhang J.G., Wang Q., et al. Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 2009, 74:213-221.
13. Cao M., Yie S.M., Liu J., Ye S.R., Xia D., Gao E. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens 2011, 78:120-128.
14. Hviid T.V., Hylenius S., Rorbye C., Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003, 55:63-79.
15. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003, 64:1005-1010.
16. Castelli E.C., Mendes-Junior C.T., Viana de Camargo J.L., Donadi E.A. HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 2008, 72:149-157.
17. Teixeira A.C., Mendes-Junior C.T., Souza F.F., Marano L.A., Deghaide N.H., Ferreira S.C., et al. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population. Tissue Antigens 2013, 81:408-413.
18. Kim S.K., Chung J.H., Jeon J.W., Park J.J., Cha J.M., Joo K.R., et al. Association between HLA-G 14-bp insertion/deletion polymorphism and hepatocellular carcinoma in Korean patients with chronic hepatitis B viral infection. Hepatogastroenterology 2013, 60:796-798.
19. Ferguson R., Ramanakumar A.V., Koushik A., Coutlee F., Franco E., Roger M. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer 2012, 131:E312-E319.
20. Silva I.D., Muniz Y.C., Sousa M.C., Silva K.R., Castelli E.C., Filho J.C., et al. HLA-G 3'UTR polymorphisms in high grade and invasive cervico-vaginal cancer. Hum Immunol 2013, 74:452-458.
21. Bortolotti D., Gentili V., Rotola A., Di Luca D., Rizzo R. Implication of HLA-G 3' untranslated region polymorphisms in human papillomavirus infection. Tissue Antigens 2014, 83:113-118.
22. Yang Y.C., Chang T.Y., Chen T.C., Lin W.S., Chang S.C., Lee Y.J. Human leucocyte antigen-G polymorphisms are associated with cervical squamous cell carcinoma risk in Taiwanese women. Eur J Cancer 2014, 50:469-474.
23. Lau D.T., Norris M.D., Marshall G.M., Haber M., Ashton L.J. HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma. Tissue Antigens 2011, 78:421-427.
24. Chen Y., Gao X.J., Deng Y.C., Zhang H.X. Relationship between HLA-G gene polymorphism and the susceptibility of esophageal cancer in Kazakh and Han nationality in Xinjiang. Biomarkers 2012, 17:9-15.
25. Eskandari-Nasab E., Hashemi M., Hasani S.S., Omrani M., Taheri M., Mashhadi M.A. Association between HLA-G 3'UTR 14-bp ins/del polymorphism and susceptibility to breast cancer. Cancer Biomark 2013, 13:253-259.
26. Ramos C.S., Goncalves A.S., Marinho L.C., Gomes Avelino M.A., Saddi V.A., Lopes A.C., et al. Analysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinoma. Hum Immunol 2014, 75:667-672.
27. Jeong S., Park S., Park B.W., Park Y., Kwon O.J., Kim H.S. Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients. PLoS One 2014, 9:e98284.
28. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
29. Ge Y.Z., Wu R., Jia R.P., Liu H., Yu P., Zhao Y., et al. Association between interferon gamma +874 T>A polymorphism and acute renal allograft rejection: evidence from published studies. Mol Biol Rep 2013, 40:6043-6051.
30. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
31. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
32. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
33. *3 polymorphism and cancer risk: a meta-analysis and meta-regression. Tumour Biol 2013, 34:2357-2366.
34. Thakkinstian A., McElduff P., D'Este C., Duffy D., Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005, 24:1291-1306.
35. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
36. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
37. Sheu J. Shih Ie M. HLA-G and immune evasion in cancer cells. J Formos Med Assoc 2010, 109:248-257.
38. Fainardi E., Castellazzi M., Stignani M., Morandi F., Sana G., Gonzalez R., et al. Emerging topics and new perspectives on HLA-G. Cell Mol Life Sci 2011, 68:433-451.